ST Pharm Co.Ltd (237690) — Cash Flow Quality Index
ST Pharm Co.Ltd (237690) has a Cash Flow Quality Index of -0.68x as of December 2025. Operating cash flow of ₩-21.16 Billion is below net income of ₩30.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of ST Pharm Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ST Pharm Co.Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for ST Pharm Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 237690 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year earnings quality comparison for ST Pharm Co.Ltd. For live market cap and the full company financial profile, see 237690 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩13.99 Billion | ₩54.99 Billion | ▼ -94.4% |
| 2024 | 4.56x | ₩109.45 Billion | ₩24.02 Billion | ▲ +6049.4% |
| 2023 | 0.07x | ₩1.30 Billion | ₩17.52 Billion | ▼ -80.1% |
| 2022 | 0.37x | ₩7.03 Billion | ₩18.85 Billion | ▼ -75.8% |
| 2021 | 1.54x | ₩7.27 Billion | ₩4.71 Billion | ▲ +27.5% |
| 2017 | 1.21x | ₩54.44 Billion | ₩45.00 Billion | ▲ +46.4% |
| 2016 | 0.83x | ₩50.78 Billion | ₩61.43 Billion | ▼ -41.9% |
| 2015 | 1.42x | ₩35.82 Billion | ₩25.19 Billion | — |